Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
Gandhi S, Opyrchal M, Grimm MJ, Slomba RT, Kokolus KM, Witkiewicz A, Attwood K, Groman A, Williams L, Tarquini ML, Wallace PK, Soh KT, Minderman H, Maguire O, O'Connor TL, Early AP, Levine EG, Kalinski P.
Gandhi S, et al.
J Immunother Cancer. 2023 Nov;11(11):e007381. doi: 10.1136/jitc-2023-007381.
J Immunother Cancer. 2023.
PMID: 37963636
Free PMC article.